Enovix (NASDAQ:ENVX) Shares Gap Down on Analyst Downgrade

Enovix Co. (NASDAQ:ENVXGet Free Report)’s share price gapped down prior to trading on Thursday after Craig Hallum lowered their price target on the stock from $20.00 to $18.00. The stock had previously closed at $11.19, but opened at $10.26. Craig Hallum currently has a buy rating on the stock. Enovix shares last traded at $10.97, with a volume of 3,905,697 shares.

Other equities analysts also recently issued research reports about the stock. Benchmark restated a “buy” rating and set a $25.00 price objective on shares of Enovix in a report on Wednesday, October 30th. Janney Montgomery Scott lowered shares of Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price target on the stock. in a research note on Thursday, October 31st. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $30.00 price objective on shares of Enovix in a research note on Thursday. Two analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Enovix currently has an average rating of “Moderate Buy” and a consensus price target of $20.30.

Read Our Latest Stock Analysis on Enovix

Insider Activity at Enovix

In other Enovix news, Director Betsy S. Atkins sold 75,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $9.73, for a total transaction of $729,750.00. Following the completion of the sale, the director now directly owns 99,497 shares in the company, valued at approximately $968,105.81. The trade was a 42.98 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 15.70% of the stock is owned by company insiders.

Institutional Trading of Enovix

A number of hedge funds have recently bought and sold shares of ENVX. Prospera Private Wealth LLC purchased a new stake in shares of Enovix in the 3rd quarter valued at approximately $27,000. Fifth Third Bancorp lifted its holdings in Enovix by 66.7% in the fourth quarter. Fifth Third Bancorp now owns 2,500 shares of the company’s stock valued at $27,000 after acquiring an additional 1,000 shares during the last quarter. Coppell Advisory Solutions LLC purchased a new position in Enovix in the fourth quarter worth approximately $27,000. Sava Infond d.o.o. acquired a new stake in Enovix during the fourth quarter worth $43,000. Finally, Hollencrest Capital Management raised its position in Enovix by 61.4% in the fourth quarter. Hollencrest Capital Management now owns 5,256 shares of the company’s stock valued at $57,000 after purchasing an additional 2,000 shares during the period. Institutional investors and hedge funds own 50.92% of the company’s stock.

Enovix Trading Down 3.5 %

The company has a 50 day moving average price of $11.06 and a 200 day moving average price of $10.29. The company has a debt-to-equity ratio of 0.99, a quick ratio of 3.61 and a current ratio of 3.77. The firm has a market cap of $1.92 billion, a price-to-earnings ratio of -6.77 and a beta of 1.87.

Enovix (NASDAQ:ENVXGet Free Report) last issued its quarterly earnings data on Wednesday, February 19th. The company reported ($0.17) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.01. The business had revenue of $9.72 million during the quarter, compared to analysts’ expectations of $8.77 million. Enovix had a negative return on equity of 102.19% and a negative net margin of 1,180.21%. On average, research analysts expect that Enovix Co. will post -1.16 earnings per share for the current year.

About Enovix

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Further Reading

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.